Seeking men and women over 18 years of age who have relapsed or refratory B-cell lymphoma after first line chemoimmunotherapy for participation in a study looking at an investigational drug in combination with other drugs
We are studying the effect of an investigational drug called glofitamab and how well it works and how safe it is, in combination with other drugs, for patients with a specfic kind of blood cancer called B-Cell Lymphoma.
What we're hoping for
To evaluate how safe and how well the investigational drug glofitamab works in combination with other drugs in patients with this specific kind of blood cancer.
ClinicalTrials.gov Identifier: NCT05364424